PDB Short entry for 1LD8 HEADER TRANSFERASE 08-APR-02 1LD8 TITLE CO-CRYSTAL STRUCTURE OF HUMAN FARNESYLTRANSFERASE WITH TITLE 2 FARNESYLDIPHOSPHATE AND INHIBITOR COMPOUND 49 CAVEAT 1LD8 U49 B 1003 HAS WRONG CHIRALITY AT ATOM C17 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN FARNESYLTRANSFERASE ALPHA SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CAAX FARNESYLTRANSFERASE ALPHA SUBUNIT, RAS PROTEINS COMPND 5 PRENYLTRANSFERASE ALPHA, FTASE-ALPHA; COMPND 6 EC: 2.5.1.-; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: PROTEIN FARNESYLTRANSFERASE BETA SUBUNIT; COMPND 10 CHAIN: B; COMPND 11 SYNONYM: CAAX FARNESYLTRANSFERASE BETA SUBUNIT, RAS PROTEINS COMPND 12 PRENYLTRANSFERASE BETA, FTASE-BETA; COMPND 13 EC: 2.5.1.-; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ALPHA-ALPHA BARREL, INHIBITOR, FTASE, PFTASE, FPP, CAAX, RAS, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.S.TAYLOR,K.L.TERRY,L.S.BEESE REVDAT 4 16-AUG-23 1LD8 1 HETSYN REVDAT 3 29-JUL-20 1LD8 1 CAVEAT COMPND REMARK SEQADV REVDAT 3 2 1 HET HETNAM HETSYN FORMUL REVDAT 3 3 1 LINK SITE ATOM REVDAT 2 24-FEB-09 1LD8 1 VERSN REVDAT 1 19-JUN-02 1LD8 0 JRNL AUTH I.M.BELL,S.N.GALLICCHIO,M.ABRAMS,L.S.BEESE,D.C.BESHORE, JRNL AUTH 2 H.BHIMNATHWALA,M.J.BOGUSKY,C.A.BUSER,J.C.CULBERSON,J.DAVIDE, JRNL AUTH 3 M.ELLIS-HUTCHINGS,C.FERNANDES,J.B.GIBBS,S.L.GRAHAM, JRNL AUTH 4 K.A.HAMILTON,G.D.HARTMAN,D.C.HEIMBROOK,C.F.HOMNICK, JRNL AUTH 5 H.E.HUBER,J.R.HUFF,K.KASSAHUN,K.S.KOBLAN,N.E.KOHL, JRNL AUTH 6 R.B.LOBELL,J.J.LYNCH JR.,R.ROBINSON,A.D.RODRIGUES, JRNL AUTH 7 J.S.TAYLOR,E.S.WALSH,T.M.WILLIAMS,C.B.ZARTMAN JRNL TITL 3-AMINOPYRROLIDINONE FARNESYLTRANSFERASE INHIBITORS: DESIGN JRNL TITL 2 OF MACROCYCLIC COMPOUNDS WITH IMPROVED PHARMACOKINETICS AND JRNL TITL 3 EXCELLENT CELL POTENCY. JRNL REF J.MED.CHEM. V. 45 2388 2002 JRNL REFN ISSN 0022-2623 JRNL PMID 12036349 JRNL DOI 10.1021/JM010531D REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.85 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2579340.410 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 80.8 REMARK 3 NUMBER OF REFLECTIONS : 87133 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.202 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4385 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.91 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 25.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4399 REMARK 3 BIN R VALUE (WORKING SET) : 0.4530 REMARK 3 BIN FREE R VALUE : 0.4540 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 229 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.030 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5877 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 89 REMARK 3 SOLVENT ATOMS : 691 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.31000 REMARK 3 B22 (A**2) : 0.31000 REMARK 3 B33 (A**2) : -0.63000 REMARK 3 B12 (A**2) : 1.96000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.27 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.28 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.770 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.640 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.090 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.010 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 1.610 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 49.85 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : SUCROSE.PAR REMARK 3 PARAMETER FILE 5 : ACETATE.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : SUCROSE.TOP REMARK 3 TOPOLOGY FILE 5 : ACETATE.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1LD8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-APR-02. REMARK 100 THE DEPOSITION ID IS D_1000015854. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-FEB-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : YALE MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 88092 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 31.020 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 81.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.91 REMARK 200 COMPLETENESS FOR SHELL (%) : 26.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1JCQ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG8K, NH4OAC, PH 5.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 21.48700 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 42.97400 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 32.23050 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 53.71750 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 10.74350 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -57.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 THR A 4 REMARK 465 GLU A 5 REMARK 465 GLY A 6 REMARK 465 VAL A 7 REMARK 465 GLY A 8 REMARK 465 GLU A 9 REMARK 465 ALA A 10 REMARK 465 ALA A 11 REMARK 465 GLN A 12 REMARK 465 GLY A 13 REMARK 465 GLY A 14 REMARK 465 GLU A 15 REMARK 465 PRO A 16 REMARK 465 GLY A 17 REMARK 465 GLN A 18 REMARK 465 PRO A 19 REMARK 465 ALA A 20 REMARK 465 GLN A 21 REMARK 465 PRO A 22 REMARK 465 PRO A 23 REMARK 465 PRO A 24 REMARK 465 GLN A 25 REMARK 465 PRO A 26 REMARK 465 HIS A 27 REMARK 465 PRO A 28 REMARK 465 PRO A 29 REMARK 465 PRO A 30 REMARK 465 PRO A 31 REMARK 465 GLN A 32 REMARK 465 GLN A 33 REMARK 465 GLN A 34 REMARK 465 HIS A 35 REMARK 465 LYS A 36 REMARK 465 GLU A 37 REMARK 465 GLU A 38 REMARK 465 MET A 39 REMARK 465 ALA A 40 REMARK 465 ALA A 41 REMARK 465 GLU A 42 REMARK 465 ALA A 43 REMARK 465 GLY A 44 REMARK 465 GLU A 45 REMARK 465 ALA A 46 REMARK 465 VAL A 47 REMARK 465 ALA A 48 REMARK 465 SER A 49 REMARK 465 PRO A 50 REMARK 465 MET A 51 REMARK 465 ASP A 52 REMARK 465 ASP A 53 REMARK 465 GLY A 54 REMARK 465 SER A 368 REMARK 465 THR A 369 REMARK 465 GLU A 370 REMARK 465 ASN A 371 REMARK 465 ASP A 372 REMARK 465 SER A 373 REMARK 465 PRO A 374 REMARK 465 THR A 375 REMARK 465 ASN A 376 REMARK 465 VAL A 377 REMARK 465 GLN A 378 REMARK 465 GLN A 379 REMARK 465 GLU A 380 REMARK 465 GLU A 381 REMARK 465 PHE A 382 REMARK 465 MET B 501 REMARK 465 ALA B 502 REMARK 465 SER B 503 REMARK 465 PRO B 504 REMARK 465 SER B 505 REMARK 465 SER B 506 REMARK 465 PHE B 507 REMARK 465 THR B 508 REMARK 465 TYR B 509 REMARK 465 TYR B 510 REMARK 465 CYS B 511 REMARK 465 PRO B 512 REMARK 465 PRO B 513 REMARK 465 SER B 514 REMARK 465 SER B 515 REMARK 465 SER B 516 REMARK 465 GLU B 924 REMARK 465 GLU B 925 REMARK 465 LEU B 926 REMARK 465 LYS B 927 REMARK 465 ASP B 928 REMARK 465 GLU B 929 REMARK 465 THR B 930 REMARK 465 SER B 931 REMARK 465 ALA B 932 REMARK 465 GLU B 933 REMARK 465 PRO B 934 REMARK 465 ALA B 935 REMARK 465 THR B 936 REMARK 465 ASP B 937 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 808 CA - CB - CG ANGL. DEV. = -14.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 88 43.12 39.00 REMARK 500 LYS A 164 76.65 -100.89 REMARK 500 LEU A 215 59.46 -107.22 REMARK 500 THR A 247 -85.09 -108.74 REMARK 500 SER A 305 -82.93 -98.90 REMARK 500 HIS A 306 32.58 -69.85 REMARK 500 SER A 307 178.64 -56.75 REMARK 500 SER A 308 164.51 159.40 REMARK 500 GLU A 347 -52.03 -131.53 REMARK 500 ASP A 349 51.45 -152.05 REMARK 500 ASN B 565 -121.79 58.54 REMARK 500 SER B 599 32.62 -144.10 REMARK 500 SER B 826 -18.30 -145.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B1001 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 797 OD1 REMARK 620 2 ASP B 797 OD2 56.1 REMARK 620 3 CYS B 799 SG 88.8 101.9 REMARK 620 4 HIS B 862 NE2 88.4 123.7 121.4 REMARK 620 5 U49 B1003 N33 153.8 97.8 99.4 107.7 REMARK 620 N 1 2 3 4 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1LD7 RELATED DB: PDB REMARK 900 HUMAN FARNESYLTRANSFERASE WITH FPP AND INHIBITOR COMPOUND 66 REMARK 900 RELATED ID: 1JCQ RELATED DB: PDB REMARK 900 HUMAN FARNESYLTRANSFERASE WITH FPP AND INHIBITOR COMPOUND L-739,750 DBREF 1LD8 A 1 379 UNP P49354 PFTA_HUMAN 1 379 DBREF 1LD8 B 501 937 UNP P49356 PFTB_HUMAN 1 437 SEQADV 1LD8 GLU A 380 UNP P49354 CLONING ARTIFACT SEQADV 1LD8 GLU A 381 UNP P49354 CLONING ARTIFACT SEQADV 1LD8 PHE A 382 UNP P49354 CLONING ARTIFACT SEQRES 1 A 382 MET ALA ALA THR GLU GLY VAL GLY GLU ALA ALA GLN GLY SEQRES 2 A 382 GLY GLU PRO GLY GLN PRO ALA GLN PRO PRO PRO GLN PRO SEQRES 3 A 382 HIS PRO PRO PRO PRO GLN GLN GLN HIS LYS GLU GLU MET SEQRES 4 A 382 ALA ALA GLU ALA GLY GLU ALA VAL ALA SER PRO MET ASP SEQRES 5 A 382 ASP GLY PHE VAL SER LEU ASP SER PRO SER TYR VAL LEU SEQRES 6 A 382 TYR ARG ASP ARG ALA GLU TRP ALA ASP ILE ASP PRO VAL SEQRES 7 A 382 PRO GLN ASN ASP GLY PRO ASN PRO VAL VAL GLN ILE ILE SEQRES 8 A 382 TYR SER ASP LYS PHE ARG ASP VAL TYR ASP TYR PHE ARG SEQRES 9 A 382 ALA VAL LEU GLN ARG ASP GLU ARG SER GLU ARG ALA PHE SEQRES 10 A 382 LYS LEU THR ARG ASP ALA ILE GLU LEU ASN ALA ALA ASN SEQRES 11 A 382 TYR THR VAL TRP HIS PHE ARG ARG VAL LEU LEU LYS SER SEQRES 12 A 382 LEU GLN LYS ASP LEU HIS GLU GLU MET ASN TYR ILE THR SEQRES 13 A 382 ALA ILE ILE GLU GLU GLN PRO LYS ASN TYR GLN VAL TRP SEQRES 14 A 382 HIS HIS ARG ARG VAL LEU VAL GLU TRP LEU ARG ASP PRO SEQRES 15 A 382 SER GLN GLU LEU GLU PHE ILE ALA ASP ILE LEU ASN GLN SEQRES 16 A 382 ASP ALA LYS ASN TYR HIS ALA TRP GLN HIS ARG GLN TRP SEQRES 17 A 382 VAL ILE GLN GLU PHE LYS LEU TRP ASP ASN GLU LEU GLN SEQRES 18 A 382 TYR VAL ASP GLN LEU LEU LYS GLU ASP VAL ARG ASN ASN SEQRES 19 A 382 SER VAL TRP ASN GLN ARG TYR PHE VAL ILE SER ASN THR SEQRES 20 A 382 THR GLY TYR ASN ASP ARG ALA VAL LEU GLU ARG GLU VAL SEQRES 21 A 382 GLN TYR THR LEU GLU MET ILE LYS LEU VAL PRO HIS ASN SEQRES 22 A 382 GLU SER ALA TRP ASN TYR LEU LYS GLY ILE LEU GLN ASP SEQRES 23 A 382 ARG GLY LEU SER LYS TYR PRO ASN LEU LEU ASN GLN LEU SEQRES 24 A 382 LEU ASP LEU GLN PRO SER HIS SER SER PRO TYR LEU ILE SEQRES 25 A 382 ALA PHE LEU VAL ASP ILE TYR GLU ASP MET LEU GLU ASN SEQRES 26 A 382 GLN CYS ASP ASN LYS GLU ASP ILE LEU ASN LYS ALA LEU SEQRES 27 A 382 GLU LEU CYS GLU ILE LEU ALA LYS GLU LYS ASP THR ILE SEQRES 28 A 382 ARG LYS GLU TYR TRP ARG TYR ILE GLY ARG SER LEU GLN SEQRES 29 A 382 SER LYS HIS SER THR GLU ASN ASP SER PRO THR ASN VAL SEQRES 30 A 382 GLN GLN GLU GLU PHE SEQRES 1 B 437 MET ALA SER PRO SER SER PHE THR TYR TYR CYS PRO PRO SEQRES 2 B 437 SER SER SER PRO VAL TRP SER GLU PRO LEU TYR SER LEU SEQRES 3 B 437 ARG PRO GLU HIS ALA ARG GLU ARG LEU GLN ASP ASP SER SEQRES 4 B 437 VAL GLU THR VAL THR SER ILE GLU GLN ALA LYS VAL GLU SEQRES 5 B 437 GLU LYS ILE GLN GLU VAL PHE SER SER TYR LYS PHE ASN SEQRES 6 B 437 HIS LEU VAL PRO ARG LEU VAL LEU GLN ARG GLU LYS HIS SEQRES 7 B 437 PHE HIS TYR LEU LYS ARG GLY LEU ARG GLN LEU THR ASP SEQRES 8 B 437 ALA TYR GLU CYS LEU ASP ALA SER ARG PRO TRP LEU CYS SEQRES 9 B 437 TYR TRP ILE LEU HIS SER LEU GLU LEU LEU ASP GLU PRO SEQRES 10 B 437 ILE PRO GLN ILE VAL ALA THR ASP VAL CYS GLN PHE LEU SEQRES 11 B 437 GLU LEU CYS GLN SER PRO GLU GLY GLY PHE GLY GLY GLY SEQRES 12 B 437 PRO GLY GLN TYR PRO HIS LEU ALA PRO THR TYR ALA ALA SEQRES 13 B 437 VAL ASN ALA LEU CYS ILE ILE GLY THR GLU GLU ALA TYR SEQRES 14 B 437 ASP ILE ILE ASN ARG GLU LYS LEU LEU GLN TYR LEU TYR SEQRES 15 B 437 SER LEU LYS GLN PRO ASP GLY SER PHE LEU MET HIS VAL SEQRES 16 B 437 GLY GLY GLU VAL ASP VAL ARG SER ALA TYR CYS ALA ALA SEQRES 17 B 437 SER VAL ALA SER LEU THR ASN ILE ILE THR PRO ASP LEU SEQRES 18 B 437 PHE GLU GLY THR ALA GLU TRP ILE ALA ARG CYS GLN ASN SEQRES 19 B 437 TRP GLU GLY GLY ILE GLY GLY VAL PRO GLY MET GLU ALA SEQRES 20 B 437 HIS GLY GLY TYR THR PHE CYS GLY LEU ALA ALA LEU VAL SEQRES 21 B 437 ILE LEU LYS ARG GLU ARG SER LEU ASN LEU LYS SER LEU SEQRES 22 B 437 LEU GLN TRP VAL THR SER ARG GLN MET ARG PHE GLU GLY SEQRES 23 B 437 GLY PHE GLN GLY ARG CYS ASN LYS LEU VAL ASP GLY CYS SEQRES 24 B 437 TYR SER PHE TRP GLN ALA GLY LEU LEU PRO LEU LEU HIS SEQRES 25 B 437 ARG ALA LEU HIS ALA GLN GLY ASP PRO ALA LEU SER MET SEQRES 26 B 437 SER HIS TRP MET PHE HIS GLN GLN ALA LEU GLN GLU TYR SEQRES 27 B 437 ILE LEU MET CYS CYS GLN CYS PRO ALA GLY GLY LEU LEU SEQRES 28 B 437 ASP LYS PRO GLY LYS SER ARG ASP PHE TYR HIS THR CYS SEQRES 29 B 437 TYR CYS LEU SER GLY LEU SER ILE ALA GLN HIS PHE GLY SEQRES 30 B 437 SER GLY ALA MET LEU HIS ASP VAL VAL LEU GLY VAL PRO SEQRES 31 B 437 GLU ASN ALA LEU GLN PRO THR HIS PRO VAL TYR ASN ILE SEQRES 32 B 437 GLY PRO ASP LYS VAL ILE GLN ALA THR THR TYR PHE LEU SEQRES 33 B 437 GLN LYS PRO VAL PRO GLY PHE GLU GLU LEU LYS ASP GLU SEQRES 34 B 437 THR SER ALA GLU PRO ALA THR ASP HET GLC C 1 11 HET FRU C 2 12 HET ACY A 904 4 HET ACY A 905 4 HET ZN B1001 1 HET FPP B1002 24 HET U49 B1003 33 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM FRU BETA-D-FRUCTOFURANOSE HETNAM ACY ACETIC ACID HETNAM ZN ZINC ION HETNAM FPP FARNESYL DIPHOSPHATE HETNAM U49 (20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12, HETNAM 2 U49 14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6, HETNAM 3 U49 9,12]OXATRI AZA-CYCLOOCTADECOSINE-9-CARBONITRILE HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN FRU BETA-D-FRUCTOSE; D-FRUCTOSE; FRUCTOSE HETSYN U49 COMPOUND 49 FORMUL 3 GLC C6 H12 O6 FORMUL 3 FRU C6 H12 O6 FORMUL 4 ACY 2(C2 H4 O2) FORMUL 6 ZN ZN 2+ FORMUL 7 FPP C15 H28 O7 P2 FORMUL 8 U49 C26 H21 N5 O2 FORMUL 9 HOH *691(H2 O) HELIX 1 1 LEU A 65 ALA A 73 5 9 HELIX 2 2 SER A 93 ASP A 110 1 18 HELIX 3 3 SER A 113 ASN A 127 1 15 HELIX 4 4 ASN A 130 LEU A 144 1 15 HELIX 5 5 ASP A 147 GLN A 162 1 16 HELIX 6 6 ASN A 165 ARG A 180 1 16 HELIX 7 7 GLN A 184 ASP A 196 1 13 HELIX 8 8 ASN A 199 PHE A 213 1 15 HELIX 9 9 ASN A 218 ASP A 230 1 13 HELIX 10 10 ASN A 233 THR A 247 1 15 HELIX 11 11 ASP A 252 VAL A 270 1 19 HELIX 12 12 ASN A 273 GLN A 285 1 13 HELIX 13 13 GLY A 288 LYS A 291 5 4 HELIX 14 14 TYR A 292 SER A 307 1 16 HELIX 15 15 SER A 308 ASN A 325 1 18 HELIX 16 16 ASN A 329 GLU A 347 1 19 HELIX 17 17 ASP A 349 ILE A 351 5 3 HELIX 18 18 ARG A 352 HIS A 367 1 16 HELIX 19 19 LEU B 523 ARG B 534 5 12 HELIX 20 20 THR B 542 SER B 561 1 20 HELIX 21 21 GLN B 574 LEU B 586 1 13 HELIX 22 22 THR B 590 ASP B 597 5 8 HELIX 23 23 SER B 599 LEU B 614 1 16 HELIX 24 24 PRO B 619 GLN B 634 1 16 HELIX 25 25 HIS B 649 GLY B 664 1 16 HELIX 26 26 THR B 665 ILE B 672 1 8 HELIX 27 27 ASN B 673 LYS B 685 1 13 HELIX 28 28 ASP B 700 THR B 714 1 15 HELIX 29 29 GLY B 724 GLN B 733 1 10 HELIX 30 30 HIS B 748 LYS B 763 1 16 HELIX 31 31 ARG B 764 LEU B 768 5 5 HELIX 32 32 ASN B 769 ARG B 780 1 12 HELIX 33 33 CYS B 799 GLN B 804 1 6 HELIX 34 34 GLY B 806 GLN B 818 1 13 HELIX 35 35 HIS B 831 CYS B 843 1 13 HELIX 36 36 ASP B 859 GLN B 874 1 16 HELIX 37 37 VAL B 889 ALA B 893 5 5 HELIX 38 38 GLY B 904 GLN B 917 1 14 SHEET 1 A 2 GLN A 89 ILE A 90 0 SHEET 2 A 2 GLN B 588 LEU B 589 1 O LEU B 589 N GLN A 89 SHEET 1 B 2 HIS B 875 SER B 878 0 SHEET 2 B 2 MET B 881 ASP B 884 -1 O MET B 881 N SER B 878 LINK C1 GLC C 1 O2 FRU C 2 1555 1555 1.47 LINK OD1 ASP B 797 ZN ZN B1001 1555 1555 2.53 LINK OD2 ASP B 797 ZN ZN B1001 1555 1555 2.03 LINK SG CYS B 799 ZN ZN B1001 1555 1555 2.38 LINK NE2 HIS B 862 ZN ZN B1001 1555 1555 2.08 LINK ZN ZN B1001 N33 U49 B1003 1555 1555 1.97 CRYST1 178.134 178.134 64.461 90.00 90.00 120.00 P 61 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005614 0.003241 0.000000 0.00000 SCALE2 0.000000 0.006482 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015513 0.00000